Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Clinical outcomes associated with azacitidine...
Conference

Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naive, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.

Authors

Hasegawa K; Wei AH; Garcia-Manero G; Daver NG; Rajakumaraswamy N; Iqbal S; Chan RJ; Hu H; Tse P; Yan J

Volume

40

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

June 1, 2022

Name of conference

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

ELECTR NETWORK

Conference start date

June 3, 2022

Conference end date

June 7, 2022

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)